Discover 2,355 paid clinical trials in Joliet, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,355
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
for
Chronic Kidney Disease (CKD)
Location: Chicago IL, Minneapolis MN, Baltimore MD,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70
Code: NCT05106387
Recruiting
Tibial IMN Vs. Tibial Micromotion IMN
for
Tibial Fracture
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT06976801
Recruiting
J-Tip Use for Paracentesis in Adults With Ascites
for
Evaluate Patient Comfort Level During Paracentesis by Numbing Skin With a Needle-less Device, Instead of Using a Needle to Numb the Skin,
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT06996379
Recruiting
Accelerometer Measured Early Recovery After Prolapse Surgery
for
Pelvic Organ Prolapse, Pelvic Organ Prolapse (POP),
Location: Chicago IL, Durham NC, Philadelphia PA, Providence RI,
Sponsor: NICHD Pelvic Floor Disorders Network
Sex: Female
Age: 18 - 70+
Code: NCT07218016
Recruiting
BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer
for
Breast Cancer, HER2-positive Breast Cancer
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18+
Code: NCT06441890
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
for
Infusion Reactions
Location: Chicago IL, Milwaukee WI, Madison WI, Indianapolis IN,
Sponsor: New York Blood Center
Sex: All
Age: 0+
Code: NCT01656603
Phase2, Recruiting
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: Chicago IL, St Louis MO, Cincinnati OH, Detroit MI,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06103864
Phase3, Recruiting
Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer